Drug Shortage Report for DEXAMETHASONE-OMEGA

Last updated on 2026-03-03

Report ID 278479
Drug Identification Number 02204266
Brand name DEXAMETHASONE-OMEGA
Common or Proper name DEXAMETHASONE SODIUM PHOSPHATE INJECTION 4MG/ML
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) DEXAMETHASONE PHOSPHATE
Strength(s) 4MG
Dosage form(s) LIQUID
Route of administration SOFT TISSUE INJECTION INTRAVENOUS INTRAMUSCULAR INTRALESIONAL INTRA-ARTICULAR SOFT TISSUE INJECTION INTRAVENOUS INTRAMUSCULAR INTRALESIONAL INTRA-ARTICULAR
Packaging size 10 x 1 mL vial / fiole
ATC code H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2026-02-20
Estimated end date 2026-05-01
Actual end date
Shortage status Actual shortage
Updated date 2026-03-03
Company comments PRODUCT ON ALLOCATION
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information [email protected] - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2026-03-03 French Compare
v3 2026-03-03 English Compare
v2 2026-02-20 French Compare
v1 2026-02-20 English Compare

Showing 1 to 4 of 4